Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Long-Term T Cell Expansion Results in Increased Numbers of Central Memory T Cells with Sustained Functional Properties for Adoptive T Cell Therapy

Stefanie Herda, PhD, Andreas Heimann, MSc, Stefanie Althoff, MSc, Josefine Ruß, Lars Bullinger, Dieter Beule, PhD, Benedikt Obermayer, PhD, Il-Kang Na, MD

Blood (2019) 134 (Supplement_1): 1943.

https://doi.org/10.1182/blood-2019-124736

Published: 2019

Journal Articles

CXCR4 Blockade By BL-8040 in T Cell Acute Lymphoblastic Leukemia Decreases Mitochondrial Mass and Induces Non-Apoptotic Cell Death

Jun Xia, PhD, Stephanie Sun, Matthew RM Jotte, Geoffrey L. Uy, MD, Osnat Bohana-Kashtan, PhD, Ella Sorani, PhD, Abi Vainstein, Amnon Peled, PhD, Daniel C. Link, MD

Blood (2019) 134 (Supplement_1): 2745.

https://doi.org/10.1182/blood-2019-128881

Published: 2019

Journal Articles

AMV564, a Bivalent Bispecific (2×2) CD33/CD3 T-Cell Engager, Is Active and Improves Survival in a Mouse Model of Acute Myeloid Leukemia

Linda G Eissenberg, PhD, Julie Ritchey, Michael P. Rettig, PhD, Judith A. Fox, PhD, Jeanmarie Guenot, PhD, John F. DiPersio, MD PhD

Blood (2018) 132 (Supplement 1): 2727.

https://doi.org/10.1182/blood-2018-99-118573

Published: 2018

Journal Articles

Modeling Sézary Syndrome for Immunophenotyping and Anti-Tumor Effect of Ucart and Long-Acting Interleukin-7 Combination Therapy

Karl W. Staser, MD PhD, Matthew L. Cooper, PhD, Jaebok Choi, PhD, Anand Chukka, Kidist Ashami, BA, Jessica Niswonger, Jaehan Park, Byung Ha Lee, PhD, Shunqiang Li, PhD, Amanda F Cashen, MD, Amy Musiek, MD, John F. DiPersio, MD PhD

Blood (2018) 132 (Supplement 1): 340.

https://doi.org/10.1182/blood-2018-99-119375

Published: 2018

Journal Articles

A Novel Bioluminescent Mouse Model for Optimization of Adoptive T Cell Therapy

Martin Szyska, PhD, Stefanie Herda, PhD, Stefanie Althoff, Andreas Heimann, Tra My Dang, Bernd Dörken, MD PhD, Thomas Blankenstein, Il-Kang Na, MD

Blood (2016) 128 (22): 2162.

https://doi.org/10.1182/blood.V128.22.2162.2162

Published: 2016

Journal Articles

A Novel Small Animal Model to Test on-Target Off-Tumor Cytoxicity of Adoptive Immune Therapies

Mauro Castellarin, PhD, Joseph A. Fraietta, PhD, Jihyun Lee, PhD, John Scholler, Yangbing Zhao, PhD MD, Carl H. June, MD

Blood (2015) 126 (23): 5432.

https://doi.org/10.1182/blood.V126.23.5432.5432

Published: 2015

Journal Articles

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

Marco Ruella, MD, David M. Barrett, MD PhD, Saad S Kenderian, MD, Olga Shestova, PhD, Ted J. Hofmann, PhD, John Scholler, Simon F. Lacey, PhD BSc, J. Joseph Melenhorst, PhD, Farzana Nazimuddin, Jessica Perazzelli, PhD, David A Christian, PhD, Christopher A Hunter, PhD, David L Porter, MD, Carl H. June, MD, Stephan A. Grupp, MD PhD, Saar I Gill, MBBS, PhD

Blood (2015) 126 (23): 2523.

https://doi.org/10.1182/blood.V126.23.2523.2523

Published: 2015

Journal Articles

G-CSF Augments Inotuzamab-Mediated Clearance of Acute Lymphoblastic Leukemia from the Bone Marrow

Jun Xia, Daniel C. Link, MD, Geoffrey L. Uy, MD

Blood (2014) 124 (21): 5502.

https://doi.org/10.1182/blood.V124.21.5502.5502

Published: 2014

Journal Articles

Targeting CD123 In Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs ® )

Muneera H. AL Hussaini, MBBS, Julie Ritchey, Michael P. Rettig, PhD, Linda Eissenberg, PhD, Geoffrey L. Uy, MD, Gurunadh Chichili, PhD, Paul A Moore, PhD, Syd Johnson, PhD, Lynne Collins, Ezio Bonvini, John F. DiPersio, MD, PhD

Blood (2013) 122 (21): 360.

https://doi.org/10.1182/blood.V122.21.360.360

Published: 2013

Journal Articles

Effect of In Vivo Azacitidine on GvHD and Gvl: Mechanistic Studies

Jaebok Choi, PhD., Julie Ritchey, Jessica Su, Julie Prior, Edward Ziga, David Piwnica-Worms, John F. DiPersio, MD, PhD

Blood (2010) 116 (21): 2537.

https://doi.org/10.1182/blood.V116.21.2537.2537

Published: 2010

Journal Articles

Epigenetic Control of GvHD and Gvl Using the Hypomethylating Agent Azacitidine.

Jaebok Choi, PhD, Julie Ritchey, John F. DiPersio, MD, PhD

Blood (2009) 114 (22): 2447.

https://doi.org/10.1182/blood.V114.22.2447.2447

Published: 2009

Journal Articles

Concurrent Visualization of Trafficking and NFAT Signalling in Primary T Lymphocytes and T Cell Precursors In Vivo.

Il-Kang Na, MD, John Markley, MD, PhD, Jennifer Tsai, MD, Nury L. Yim, Bradley J. Beattie, Alexander D. Klose, PhD, Amanda M. Holland, Arnab Ghosh, MD, PhD, Uttam K. Rao, Matthias Stephan, MD, PhD, Inna Serganova, PhD, Renier J. Brentjens, MD, PhD, Ron R.G. Blasberg, MD, Michel W Sadelain, MD, PhD, Marcel R.M. van den Brink, MD, PhD

Blood (2009) 114 (22): 914.

https://doi.org/10.1182/blood.V114.22.914.914

Published: 2009

Journal Articles

In Vivo Bioluminescence Imaging (BLI) and Sequential 18 F]FHBG microPET Imaging Studies of Human T Cell (huT) Trafficking, Expansion and Xenogeneic Graft-Versus-Host-Disease (XGVHD) Following Different Routes of T Cell Administration.

Bruno Nervi, MD, Michael P. Rettig, PhD, Julie K. Ritchey, Hanlin L. Wang, MD,PhD, Gerhard Bauer, Jon Walker, Julie L. Prior, David Piwnica-Worms, MD,PhD, Jan A. Nolta, PhD, John F. DiPersio, MD,PhD

Blood (2006) 108 (11): 5178.

https://doi.org/10.1182/blood.V108.11.5178.5178

Published: 2006

Journal Articles

CXCR4/SDF-1 Is a Key Regulator for Leukemia Migration and Homing to the BM: Impact of AMD3100 on In Vivo Response to Chemotherapy.

Bruno Nervi, MD, Pablo Ramirez, MD, Matthew Holt, Michael P. Rettig, PhD, Julie K. Ritchey, Julie L. Prior, David Piwnica-Worms, MD,PhD, Gary Bridger, PhD, Timothy J. Ley, MD,PhD, John F. DiPersio, MD,PhD

Blood (2006) 108 (11): 569.

https://doi.org/10.1182/blood.V108.11.569.569

Published: 2006

Journal Articles

AMD3100 Mobilizes Acute Promyelocytic Leukemia Cells from the Bone Marrow into the Peripheral Blood and Sensitizes Leukemia Cells to Chemotherapy.

Bruno Nervi, MD, Matthew Holt, Michael P. Rettig, PhD, Gary Bridger, PhD, Timothy J. Ley, MD, PhD, John F. DiPersio, MD, PhD

Blood (2005) 106 (11): 246.

https://doi.org/10.1182/blood.V106.11.246.246

Published: 2005

Journal Articles

Comparison of the Proliferative Kinetics, GVHD Potential and GCV Sensitivity of Naive and Transduced and Selected Murine T Cells after Allogeneic BMT.

Michael Rettig, PhD, Julie Ritchey, Julie Prior, David Piwnica-Worms, MD/PhD, Mark Bonyhadi, PhD, John DiPersio, MD/PhD.

Blood (2005) 106 (11): 5257.

https://doi.org/10.1182/blood.V106.11.5257.5257

Published: 2005

Journal Articles

Regulation of PDZ-Binding Kinase (PBK) in Hematopoietic Tumors.

Asit K. Nandi, Ph.D, Katherine R. Goetzinger, Jennie Hart, Jeffrey Kleinberg, Dina Ioffe, Paul S. Shapiro, Ph.D, Aaron P. Rapoport, MD

Blood (2004) 104 (11): 4287.

https://doi.org/10.1182/blood.V104.11.4287.4287

Published: 2004

Journal Articles

In Vivo Bioluminescence Imaging of Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation with Ex Vivo Manipulated Murine T Cells.

Michael P. Rettig, Ph.D., Julie K. Ritchey, Julie L. Prior, David Piwnica-Worms, M.D./Ph.D., Mark L. Bonyhadi, Ph.D., John F. DiPersio, M.D./Ph.D.

Blood (2004) 104 (11): 3066.

https://doi.org/10.1182/blood.V104.11.3066.3066

Published: 2004

NARROW

Long-Term T Cell Expansion Results in Increased Numbers of Central Memory T Cells with Sustained Functional Properties for Adoptive T Cell Therapy

CXCR4 Blockade By BL-8040 in T Cell Acute Lymphoblastic Leukemia Decreases Mitochondrial Mass and Induces Non-Apoptotic Cell Death

AMV564, a Bivalent Bispecific (2×2) CD33/CD3 T-Cell Engager, Is Active and Improves Survival in a Mouse Model of Acute Myeloid Leukemia

Modeling Sézary Syndrome for Immunophenotyping and Anti-Tumor Effect of Ucart and Long-Acting Interleukin-7 Combination Therapy

A Novel Bioluminescent Mouse Model for Optimization of Adoptive T Cell Therapy

A Novel Small Animal Model to Test on-Target Off-Tumor Cytoxicity of Adoptive Immune Therapies

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

G-CSF Augments Inotuzamab-Mediated Clearance of Acute Lymphoblastic Leukemia from the Bone Marrow

Targeting CD123 In Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs ® )

Effect of In Vivo Azacitidine on GvHD and Gvl: Mechanistic Studies

Epigenetic Control of GvHD and Gvl Using the Hypomethylating Agent Azacitidine.

Concurrent Visualization of Trafficking and NFAT Signalling in Primary T Lymphocytes and T Cell Precursors In Vivo.

In Vivo Bioluminescence Imaging (BLI) and Sequential 18 F]FHBG microPET Imaging Studies of Human T Cell (huT) Trafficking, Expansion and Xenogeneic Graft-Versus-Host-Disease (XGVHD) Following Different Routes of T Cell Administration.

CXCR4/SDF-1 Is a Key Regulator for Leukemia Migration and Homing to the BM: Impact of AMD3100 on In Vivo Response to Chemotherapy.

AMD3100 Mobilizes Acute Promyelocytic Leukemia Cells from the Bone Marrow into the Peripheral Blood and Sensitizes Leukemia Cells to Chemotherapy.

Comparison of the Proliferative Kinetics, GVHD Potential and GCV Sensitivity of Naive and Transduced and Selected Murine T Cells after Allogeneic BMT.

Regulation of PDZ-Binding Kinase (PBK) in Hematopoietic Tumors.

In Vivo Bioluminescence Imaging of Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation with Ex Vivo Manipulated Murine T Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only